VRTX

Vertex Pharmaceuticals Incorporated News Headlines

$88.64
*  
3.37
3.66%
Get VRTX Alerts
*Delayed - data as of Jul. 31, 2014 13:26 ET  -  Find a broker to begin trading VRTX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    VRTX Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Vertex Pharmaceuticals Posts Wider Q2 Loss, Maintains View - Analyst Blog
7/30/2014 1:10:00 PM - Zacks.com

Nasdaq 100 Movers: GRMN, REGN
7/30/2014 11:27:43 AM - BNK Invest

Vertex Pharma Q2 Loss Widens - Quick Facts
7/29/2014 4:32:00 PM - RTT News

Vertex Pharmaceuticals Q2 14 Earnings Conference Call At 5:00 PM ET
7/29/2014 3:00:00 PM - RTT News

After-Hours Earnings Report for July 29, 2014 : AXP, AMGN, APC, ESRX, AFL, EQR, AMP, VRTX, MAR, BXP, FISV, NEM
7/29/2014 2:00:02 PM - NASDAQ.com News

Will Vertex Pharmaceuticals (VRTX) Loss be Below Estimates? - Analyst Blog
7/28/2014 4:30:00 PM - Zacks.com

Should You Buy Vertex Pharmaceuticals (VRTX) Ahead of Earnings? - Tale of the Tape
7/28/2014 8:48:00 AM - Zacks.com

Biotechs Have Their 'Irrational Exuberance' Moment: Time To Buy More?
7/21/2014 10:40:00 AM - Seeking Alpha

Biotech Stock Roundup: AbbVie Woos Shire with Revised Offer, Sarepta Slips on Eteplirsen Data - Analyst Blog
7/16/2014 9:49:00 AM - Zacks.com

Nasdaq 100 Movers: VRTX, MYL
7/14/2014 12:20:19 PM - BNK Invest

Cramer's Mad Money - The 4 Horsemen Of Biotech Ride On (7/9/14)
7/10/2014 6:27:00 AM - Seeking Alpha

Vertex Pharmaceuticals Inc. (VRTX): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report
7/8/2014 8:00:00 AM - Zacks.com

Merck, Gilead Lead Race To Eradicate Hepatitis C
7/3/2014 5:08:00 PM - Investor's Business Daily

Vertex Pharmaceuticals Up on Kalydeco sNDA Submission - Analyst Blog
7/2/2014 7:15:00 PM - Zacks.com

Biotech Stock Roundup: Vertex Jumps on Phase III Data, MannKind Scores FDA Approval - Analyst Blog
7/2/2014 10:41:00 AM - Zacks.com

Cramer's Mad Money - The Mother Of All Speculative Stocks (7/1/14)
7/2/2014 6:06:00 AM - Seeking Alpha

Vertex Submits SNDA For KALYDECO
6/30/2014 4:20:00 PM - RTT News

Vertex Pharmaceuticals' Kalydeco Wins Positive EU Opinion - Analyst Blog
6/30/2014 1:40:00 PM - Zacks.com

Are Biotech Stocks Overdue for a Summer Pullback?
6/27/2014 2:29:00 PM - Minyanville

Sector Update: Healthcare Stocks Drifting Lower; Vertex Pharma Falling Despite Recommendation For Additional Indications for Cystic Fibrosis Drug
6/27/2014 1:13:59 PM - MT Newswires

Sector Update: Healthcare
6/27/2014 1:13:21 PM - MT Newswires

Sector Update: Health Care
6/27/2014 8:59:05 AM - MT Newswires

Sector Update: Health-Care Shares Fairly Flat Pre-Market
6/27/2014 8:58:53 AM - MT Newswires

Vertex: CHMP Issues Positive Opinion On KALYDECO In Treatment Of Cystic Fibrosis
6/27/2014 7:26:00 AM - RTT News

Vertex Soars On Phase III Trial Results: Assessing The Upside Potential From Here
6/25/2014 10:57:00 AM - Seeking Alpha